Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study ; volume:271 ; number:5 ; day:2 ; month:4 ; year:2024 ; pages:2444-2445 ; date:5.2024
Journal of neurology ; 271, Heft 5 (2.4.2024), 2444-2445, 5.2024
- Urheber
-
Barbanti, Piero
Aurilia, Cinzia
Egeo, Gabriella
Proietti, Stefania
D’Onofrio, Florindo
Torelli, Paola
Aguggia, Marco
Bertuzzo, Davide
Finocchi, Cinzia
Trimboli, Michele
Cevoli, Sabina
Fiorentini, Giulia
Orlando, Bianca
Zucco, Maurizio
Clemente, Laura Di
Cetta, Ilaria
Colombo, Bruno
Poggio, Monica Laura Bandettini di
Favoni, Valentina
Grazzi, Licia
Salerno, Antonio
Carnevale, Antonio
Robotti, Micaela
Frediani, Fabio
Altamura, Claudia
Filippi, Massimo
Vernieri, Fabrizio
Bonassi, Stefano
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-024-12287-3
- URN
-
urn:nbn:de:101:1-2407111538362.360776462595
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barbanti, Piero
- Aurilia, Cinzia
- Egeo, Gabriella
- Proietti, Stefania
- D’Onofrio, Florindo
- Torelli, Paola
- Aguggia, Marco
- Bertuzzo, Davide
- Finocchi, Cinzia
- Trimboli, Michele
- Cevoli, Sabina
- Fiorentini, Giulia
- Orlando, Bianca
- Zucco, Maurizio
- Clemente, Laura Di
- Cetta, Ilaria
- Colombo, Bruno
- Poggio, Monica Laura Bandettini di
- Favoni, Valentina
- Grazzi, Licia
- Salerno, Antonio
- Carnevale, Antonio
- Robotti, Micaela
- Frediani, Fabio
- Altamura, Claudia
- Filippi, Massimo
- Vernieri, Fabrizio
- Bonassi, Stefano
- SpringerLink (Online service)
Ähnliche Objekte (12)
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
Monoclonal Antibodies Targeting CGRP to Treat Vestibular Migraine: A Rapid Systematic Review and Meta-Analysis
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study
Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population
Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
Monoclonal Antibodies Targeting CGRP to Treat Vestibular Migraine: A Rapid Systematic Review and Meta-Analysis
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study
Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population
Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
Monoclonal Antibodies Targeting CGRP to Treat Vestibular Migraine: A Rapid Systematic Review and Meta-Analysis
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study
Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population